Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report.
Ozatli D, Giden AO, Erkurt MA, Korkmaz S, Basci S, Ulas T, Turgut B, Yigenoglu TN, Hacibekiroglu T, Basturk A, Dal MS, Namdaroglu S, Hindilerden F, Hacioglu SK, Cagliyan GA, Ilhan G, Kacmaz M, Uysal A, Merter M, Ekinci O, Dursun FE, Tekinalp A, Demircioglu S, Sincan G, Acik DY, Akdeniz A, Ucar MA, Yeral M, Ciftciler R, Teke HU, Umit EG, Karakus A, Bilen Y, Yokus O, Albayrak M, Demir C, Okan V, Serefhanoglu S, Kartı S, Ozkurt ZN, Eser B, Aydogdu I, Kuku I, Cagirgan S, Sonmez M, Ozet G, Altuntas F. Ozatli D, et al. Among authors: ucar ma. Transfus Apher Sci. 2023 Apr;62(2):103662. doi: 10.1016/j.transci.2023.103662. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36842884 Review.
Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T, Sahin B, Kirazli M, Ahmed F, Aydin S, Yesil Çinkir H, Sezgin G, Bayram I, Ebinç S, Isikdogan A, Sasmaz I, Okan V, Ilhan G, Ören AC, Akbayram S, Harputluoglu H, Ural C, Ayyildiz O, Aktas G, Uçar MA, Güvenç B, Köse D, Acipayam C, Güncan S, Erçolak V, Berber I, Akdeniz A, Akyay A, Üzel VH, Söker M, Sengelen M, Yalçin S, Sullivan R. Kutluk T, et al. Among authors: ucar ma. JAMA Netw Open. 2023 May 1;6(5):e2312903. doi: 10.1001/jamanetworkopen.2023.12903. JAMA Netw Open. 2023. PMID: 37219908 Free PMC article.
Evaluation of factors affecting treatment and mortality in patients over 65 years of age and without chronic disease, followed in the Intensive Care Unit due to COVID-19.
Ilginel MT, Yesilyurt AO, Ozyilmaz E, Ilginel OO, Sener M, Tunay DL, Karacaer F, Biricik E, Ucar MA. Ilginel MT, et al. Among authors: ucar ma. Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8301-8313. doi: 10.26355/eurrev_202309_33590. Eur Rev Med Pharmacol Sci. 2023. PMID: 37750658 Free article.
Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels.
Ceran F, Akıncı S, Uçar MA, Korkmaz G, Gündüz M, Çavdarlı B, Bakanay ŞM, Falay M, Dağdaş S, Dilek İ, Özet G. Ceran F, et al. Among authors: ucar ma. Turk J Haematol. 2022 Aug 25;39(3):196-203. doi: 10.4274/tjh.galenos.2022.2022-0024. Epub 2022 May 27. Turk J Haematol. 2022. PMID: 35620443 Free PMC article.
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.
Ak MA, Sahip B, Geduk A, Ucar MA, Kale H, Hacibekiroglu T, Polat MG, Kalpakci Y, Bolaman AZ, Guvenc B, Ertop S. Ak MA, et al. Among authors: ucar ma. Indian J Hematol Blood Transfus. 2022 Apr;38(2):299-308. doi: 10.1007/s12288-021-01458-1. Epub 2021 Jun 26. Indian J Hematol Blood Transfus. 2022. PMID: 35496974 Free PMC article.
Corrigendum to "Reasons for complementary therapy use by cancer patients, information sources and communication with health professionals" [Complement Ther Med 44 (2019) 157-161].
Arıkan F, Uçar MA, Kondak Y, Tekeli A, Kartöz F, Özcan K, Göksu SS, Coşkun HŞ. Arıkan F, et al. Among authors: ucar ma. Complement Ther Med. 2021 Dec;63:102790. doi: 10.1016/j.ctim.2021.102790. Epub 2021 Nov 16. Complement Ther Med. 2021. PMID: 34799206 Free article. No abstract available.
Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.
Ucar MA, Ozet G, Koyuncu MB, Sonmez M, Akidan O, Ayli M, Yildirim M, Pehlivan M, Akkurd DM, Sahin H, Guvenc B, Okan V, Tiftik EN, Akdeniz A, Dincyurek HD, Gunes AK, Dagdas S, Acar HI, Ucar HK, Tombak A. Ucar MA, et al. Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6557-6565. doi: 10.26355/eurrev_202111_27126. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787859 Free article.
30 results